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ABSTRACT 
Ayurveda is a traditional medicine of system in India which includes plants and plant-based products for treatment and cure of diseases. 
Alangium salviifolium is an ethnomedicinal plant and has been reported to be useful against skin cancer. In the present study, we used thee 
concentrations of methanolic bark extract of A. salviifolium (MBEAS) to evaluate its anticancer activity against epidermoid carcinoma A431cells 
and melanoma B16F10 cells. Assays performed were trypan blue dye exculsion to assess the cytotoxicity, colony formation for cell growth and 
AO/EtBr staining to check the apoptotic/necrotic effect of A. salviifolium on skin cancer cells. Exposure of cells to A. salviifolium for 24 h and 48 
h strongly reduced the cell number of  A431 and B16F10 cells, inhibited the colony formation ability and induced apoptosis in a concentration-
dependent manner. The results from the study suggest the antiproliferative activity of A. salviifolium against both melanoma and non-
melanoma skin cancer cells. Overall, it provides the needed scientific validity to its traditional use against skin cancer.  
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1 INTRODUCTION 
Cancer incidences are rising around the globe. An increase in 
new cancer cases to 19.3 million per year by 2025 has been 
estimated on the basis of GLOBOCAN 2012 estimates (Ferlay 
et al., 2015). According to GLOBOCAN 2018 statistics the 
global cancer burden has increased to 18.1 million cases and 
cancer deaths to 9.6 million. According to this report, Asia is 
contributing to half of the all new cancer cases and cancer 
deaths. In these estimates, Asia and Africa have higher 
percentage of cancer deaths 7.3% and 57.3% respectively, as 
compared to global incidence of 5.8% and 48.4% 
respectively. According to the International Agency for 
Research on Cancer (IARC), this is because of the cancer 
types with poorer prognosis and also delay in diagnosis and 
lack of access to the treatment (Bray et al., 2018). Thus to 
increase the access of cancer treatment, economic and 
efficient treatment options are needed to be explored. In this 
regard, plant and plant-based products provide a good 
option because of its easy availability and relatively lesser 
side effects (Atanasov et al., 2015). 
Ethnomedicinal plants are getting much importance and 
many of them are getting evaluated for their claimed 
activities to provide with the much needed scientific 
evidence. Phytochemical and pharmacological studies of 
these plants are useful and support their traditional uses 
and provide new source for evaluation and development of 
drugs. A. salviifolium belongs to genus Alangium and family 
Alangiaceae and in local languages known as Ankora, Ankol, 
Ankolam, Ankola, etc. It is found as shrub or as small to 
medium-sized tree that has thorns and rough bark surface 
with reddish-brown fruits. In India, it is commonly found in 
Western Ghats (Tanwer, 2010). Many of the traditional use 
of A. salviifolium are as vasodilators, antidote, and purgative 
and to cure diarrhoea, asthma, eye diseases, back pain, blood 
disorders, and skin diseases (Plants, 1995; Kritikar and 
Basu, 1918; Nandakarni, 1996; Pullaiah, 2003; Panara et al 
2016). It is used by many tribes of Chhattisgarh and 
Rajasthan to treat cancer (Jain and Jain, 2010; Tanwer and 
Vijayvergia, 2014).  
Different parts of the plant have been explored for the 
phytochemical constituents that revealed the presence of 
primary metabolites such as lipids, starch, phenols, ascorbic 
acid, soluble sugars etc and secondary metabolite such as 
steroids, flavonoids, alkaloids, tannins, terpenoids and 
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glycosides (Sreekanth et al, 2011; Murugan et al 2000; Jubie, 
2008 ). Some of the medicinal properties of stem bark of A. 
salviifolium have been evaluated previously. Stem bark of A. 
salviifolium has been reported to have antimicrobial 
(Katyayani et al, 2002), anti-arthitic (Jubie, 2008), 
antidiabetic (Rajkumar and Kumar, 2011), anticonvulsant 
(Parida et al, 2010) and androgenic activity (Murugan et al, 
2000).  
Currently, there is no study reporting the anticancer activity 
of bark extract of A. salviifolium against skin cancer. 
Therefore in the present study, we evaluated the anticancer 
activity of A. salviifolium against melanoma and non-
melanoma skin cancer cells. 
2. MATERIALS AND METHODS 
2.1. Chemical and reagents 
Chemicals used for the study were 0.4% trypan blue from 
Himedia laboratories, crystal violet, acridine orange (AO) 
from Thermo Fisher Scientific, and ethidium bromide (EtBr), 
dimethyl sulfoxide (DMSO) from Sigma  (Saint  Louis,  MO,  
USA), Dulbecco’s modified Eagles medium   (DMEM;   Sigma,   
Saint   Louis,   MO, USA), fetal   bovine   serum (Gibco), 
penicillin-streptomycin (Himedia, India). Other chemicals 
and reagents used were of analytical grade. 
2.2. Plant material 
The stem bark of A. salviifolium was freshly collected from 
District Balod, Chhattisgarh, India. The plant material was 
authenticated by Dr. Mohammad Irfan Qureshi (Jamia Millia 
Islamia, New Delhi), and a voucher specimen (Acc. No. 
20150218) was deposited at the Herbarium of  PBL, 
Department of Biotechnology, Jamia Millia Islamia, New 
Delhi, India. 
2.3 Cell culture 
Cell lines used for the study are squamous cell carcinoma 
A431 cells, and melanoma B16F10 cells. It was obtained 
from National Centre for Cell Sciences (NCCS), Pune, India. 
These cells were cultured and maintained in DMEM with 
10% FBS and 1% penicillin-streptomycin-amphotericin B 
cocktail at 37° C temperature with 5% CO2 in a humidified 
cell culture incubator.  
2.4 Extract preparation 
For preparation of methanol extract of bark of A. salviifolium, 
it was air dried and grounded and then subjected to Soxhlet 
extractor. The extract was then concentrated in rotary 
vacuum evaporator at 45°C and freeze lyophilized to get the 
powder form. 
MBEAS in the dried powder form were weighed and 
dissolved in dimethyl sulfoxide (DMSO) for making the stock 
solution. For the use in experiments, it was diluted in culture 
medium at required concentrations, in which DMSO 
concentration doesn’t exceed the final concentration of 0.1% 
in all the treatment groups. The stock was stored at -20°C 
and used for future experiments. 
2.5 Trypan blue assay 
To evaluate the cytotoxic effect of MBEAS, trypan blue 
exclusion assay was performed. A431 and B16F10 cells were 
seeded at the density of 1x105 cells/well in 60 mm plates. 
Cancer cells were treated with A. salviifolium bark extract at 
the concentration of 0.05, 0.1 and 0.5 µg/ml for 24 h and 48 
h. DMSO was present in all the groups with the final 
concentration not exceeding 0.1%, v/v. After each treatment 
time points, cells were collected and mixed with trypan blue 
and counted using hemocytometer under the phase contrast 
microscope at 100X magnification, (Bhat, Nambiar, Pal, 
Agarwal, & Singh, 2012). Counting was done in duplicate and 
its average value was taken and the experimental groups 
were in triplicate. The experiment was repeated twice. 
Total cells were calculated using the following formula: 
Total cells = average number of cells counted in each 
chamber X dilution factor X 104 cells/ ml. 
2.6 Clonogenic assay  
To assess the cell survival and proliferation ability, colony 
assay was performed. Seeding density was 500 cells per well 
in 6 well culture plate, and the cells were allowed to attach 
for 24 h. After that, cells were treated with MBEAS (0.05, 0.1 
and 0.5 µg/ml) for 24 h. Post treatment time; media was 
replaced with fresh complete culture media and incubated in 
CO2 incubator. Experiment was terminated on 7th day. Plates 
were gently washed with PBS, cells were fixed with 2 ml of 
fixative (12.5% acetic acid and 30% methanol in DW) for 5 
mins at RT. Colonies were stained with 2 ml of crystal violet 
(0.5%) for 15-20 mins at RT. Colonies were observed and 
counted under phase contrast microscope at 100X 
magnification >50 cells were included in the colony 
(Nambiar et al., 2015). Experiment was performed in 
triplicates and repeated twice. 
Colony formation rate (%) was calculated using the formula; 
Colony formation rate (%) = (number of colonies formed/ 
total number of cell seeded) X 100 
2.7 AO/EtBr assay  
After the desired treatment time point of 24 h cells were 
collected by trypsinization and centrifuged. Cell pellet was 
washed with PBS (1X) and then suspended in 100 µl of PBS. 
Then from this, 10µl of cell suspension was incubated with 
2µl of AO: EtBr (1:1 of 100 µg/ml stock solution) for 2 
minutes. Stained suspension was placed on microscopic 
slide and covered with a glass cover slip, such that there is 
no air bubble trapped. Cells were examined under the 
fluorescence microscope at 100 X magnifications (Kasibhatla 
et al., 2006). A minimum of 200 were counted for analysis of 
the live, early apoptotic, late apoptotic, and necrotic 
population in the control and treated groups. Total apoptotic 
cells included both early and late apoptotic populations in 
each sample. 
2.8 Statistical analysis  
Statistical analysis was done using GraphPad Prism5 
software. Difference between groups was analyzed by 
Student’s t-test. All the data are represented as the mean ± 
standard error. A value of p ≤ 0.05 indicates a significant 
difference between the groups. 
3 RESULTS 
3.1 MBEAS decreases the proliferation of A431 and 
B16F10 cells 
In vitro cytotoxicity of the extract was determined by trypan 
blue dye exclusion assay on A431 and B16F10 cells. On 
treatment of A431 cells with MBEAS for 24 h, the total cell 
number decreased by 40 %, 60 % (p< 0.001) at lower 
concentrations of 0.5 and 0.1 µg/ml and approximately 66 % 
(p<0.001) decrease at the concentration of 0.5 µg/ml. With 
increased time period of exposure of cells to MBEAS, total 
cell number decreased significantly by around 80 to 90% 
(p<0.001) at all the three concentrations (0.05. 0.1, 0.5 
µg/ml) after 48 h of treatment (Figure 1a and 1b). In case of 
B16F10 cells, MBEAS was highly cytotoxic with around 70 % 
(p<0.01) decrease in total cell number after 24 h of 
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treatment and at higher concentration after 48 h of 
treatment, cells were barely left with around 90 % (p<0.01) 
decrease in total cell number (Figure 1c and 1d). Hence, 
MBEAS was found to be cytotoxic for both the cancer cell 
lines at all the three concentrations (0.05, 0.1, 0.5 µg/ml) 
after 24 and 48 h of treatments. 
 
 
Figure 1: Effect of MBEAS on cell viability of skin cancer cells.  Quantitative data of trypan blue exclusion assay performed 
on A431 and B16F10 cells after 24 h and 48 h treatment with MBEAS. Data are represented as total cell number as percent of 
control in A431 cells at (a) 24 h, (b) 48 h and B16F10 cells at (c) 24 h, (d) 48 h with treatments of MBEAS. Counting was done in 
duplicate and the experimental repeat was in triplicate. Data are represented as mean ± SEM, **p< 0.01 and ***p<0.001 is the 
significance difference compared to control. 
 
3.2 Decrease in the clonogenicity of skin cancer cells by 
MBEAS 
On treatment with MBEAS for 24 h resulted in decrease in 
colony numbers as well as the colony forming rate in both 
A431 and B16F10 cells. The colony having >50 cells were 
counted; with increase in concentration of treatment the size 
of the colony was also highly reduced. In A431 cells, 
treatment with  0.05 μg/ml concentration of MBEAS showed 
80 % decrease (p< 0.01) in number of colonies and colony 
forming rate (Figure 2b and 2c) as compared to control. In 
B16F10 cells the reduction was almost 90% (p<0.05) as 
compared to control. With higher concentration of MBEAS 
colony size was too small (Figure 2d and 2e). The results 
indicate that MBEAS causes a strong decrease in the 
proliferation ability of skin cancer cells. 
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Figure 2: Effect of MBEAS on clonogenicity of skin cancer cells. A431 and B16F10 cells were allowed to form colony post 24 
h treatment with MBEAS, the colony having >50 cells were counted and evaluated. Representative data of colony formation 
assay (a) and (d). Quantitative data are represented as number of colony and colony formation rate compared to control of 
A431 (b), (c) and B16F10 cells (e) and (f). The data are represented as mean ± SEM, *p<0.05, **p<0.01 represents the 
significance difference as compared to control.  
 
3.3 MBEAS treatment induces apoptosis in A431 and 
B16F10 cells 
Further to study the cell death effect of MBEAS, AO/EtBr 
staining assay was performed. Acridine orange and ethidium 
bromide dual staining method are used to stain necrotic and 
apoptotic cells. Microscopy was performed and cells in 
different fields were counted, population of necrotic cells 
was not found to be significant. After 24 h treatment of A431 
cells with MBEAS showed an increase in apoptotic cells 
percentage in a concentration-dependent manner. The 
increase was around 10%, 12% (p<0.1) and 15% (p<0.1) for 
0.05, 0.1 and 0.5 μg/ml concentrations respectively, as 
compared to control (Figure 3). Similarly, there was also an 
increase in percentage of apoptotic cells in case of B16F10 
cells. The increase was concentration-dependent with 
around 4%, 6% (p<0.05) and 8% for 0.05, 0.1 and 0.5 μg/ml 
concentration respectively as compared to control (Figure 
3). This observation indicated the apoptosis-inducing effect 
of MBEAS in skin cancer cells. 
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Figure 3: Effect of MBEAS on apoptosis in skin cancer cells. AO/EtBr dual staining assay was performed on A431 and 
B16F10 cells to detect the necrotic and apoptotic cells after 24 h treatment with MBEAS. Representative images (a) and (c) and 
quantitative data (b) and (d) of A431 and B16F10 cells showing apoptotic cells. Total 200 cells were counted to quantitate the 
apoptotic population in the respective treatment groups. Experiment was performed in triplicate and data are represented as 
mean ± SEM. *p<0.05 signifies the significant difference compared to control. 
 
4 DISCUSSION 
Studies on cancer cell lines have shown the anticancer 
activity of test compounds is exhibited by inhibiting the cell 
proliferation as well as by inducing apoptosis. The end result 
of apoptosis may be brought about by causing DNA damage 
and arresting the cell cycle (Ahamad et al., 2014; Huang et 
al., 2013; Ji Hye Kim, 2015; Pieme et al., 2014). Results from 
the present study also suggest the antiproliferative activity 
of MBEAS accompanied with induction of apoptosis in A431 
and B16F10 cells. 
The literature available about A. salviifolium have described 
it as a medicinal plant. The phytochemical analysis of bark of 
A. salviifolium has shown the presence of flavonoids, 
phenols, steroids and saponins (Tanwer and Vijayvergia, 
2014). The flavonoids and phenolic compounds present in 
plants contribute to the antioxidant and therefore the cancer 
preventive activity which has been observed in many plants 
studied. Methanolic leave and stem extract of A. salviifolium 
showed maximum antioxidant activity as compared to other 
solvent extracts and thus it might contribute to the 
anticancer activity of A. salviifolium. Many medicinal plants 
have been extensively evaluated for their anticancer 
activities and has received great attention recently. 
Camptothecin is an alkaloid that has exhibited anticancer 
activities both in vitro and in vivo. It is isolated from the 
plant, Mappia foetida and has shown inhibitory activity 
against cancer cells. Clinical trials have been underway for 
camptothecins and its analogues (Wall and Wani, 1977; 
Potmesil, 1994). Boswellia serrata has been evaluated for its 
medicinal properties and many of its pharmacological 
properties have been documented. Triterpenediol isolated 
from it is cytotoxic against many cancer cells (Syrovets et al, 
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2005; Hostanska et al, 2002; Liu et al, 1998). It inhibits DNA 
synthesis, topoisomerase induces apoptosis (Shao et al, 
1998; Lee et al 1966).  
There have been previous reports that showed the 
anticancer activity of A. salviifolium against various in vitro 
and in vivo models of cancer. It inhibits the growth of 
Daltons ascetic lymphoma murine cells (Venkateshwarlu et 
al, 2012). Flowers of A. salviifolium showed anticancer 
potential against Ehrlich ascites carcinoma model in mice 
and substantially increased the life span of tumor-bearing 
mice (Haque, 2011; Nahar et al, 2012). Some of the alkaloids 
isolated from the stem of A. salviifolium exhibited 
antioxidant activity and selectively inhibited the growth of 
HepG2 cancer cells (Phanruethai et al, 2011).  
Currently, no study has been carried out using the bark 
extract of A. salviifolium against skin cancer cells to evaluate 
its anticancer potential. So, the present study was carried 
out and we explored the anticancer activity of MBEAS on 
skin cancer A431 and B16F10 cells. Bark extract of A. 
salviifolium efficiently decreased the cell viability, cell 
proliferation and clonogenicity of epidermoid carcinoma 
A431cells and melanoma B16F10 cells at its very low 
concentrations of 0.05, 0.1, 0.5 μg/ml. For cytotoxicity study 
trypan blue exclusion assay was performed, live cells do not 
take up the dye due to membrane integrity hence it only 
stains the dead cells. There was significant decrease in cell 
number in MBEAS treatment groups compared to control 
suggesting that the increased cell death in addition to 
inhibition of cell proliferation in these treated groups. 
Further to check the effect on cell growth, colony formation 
assay was performed that indicated the decreased ability of 
cells to form colony in MBEAS treated groups as compared 
to control. The colony size was remarkably reduced at 
higher concentration of MBEAS.  
Further our results from AO/EtBr assay indicated that 
MBEAS induced apoptosis in A431 and B16F10 cells at all 
the thee tested concentrations (0.05, 0.1, 0.5 μg/ml) after 24 
h of treatment. Acridine orange (AO) stains all the cells, live 
cells as well as cells undergoing cell death. Live cells are 
stained evenly with AO but EtBr is only taken up by the cells 
undergoing death as the membrane integrity is lost and it is 
permeable to cells, where it goes and intercalates within 
DNA. Necrotic cells get evenly stained and the cell size 
increases where as in the apoptotic cells, chomatin 
condensation and fragmentation is visible.  
This is a novel study reporting the cytotoxic effect of bark 
extract of A. salviifolium against human as well as mouse skin 
cancer cells. The results from the present study on skin 
cancer cell lines provide a first line evidence for the 
anticancer activity of A. salviifolium bark. 
5 CONCLUSION 
In summary, the results from the study report the 
antiproliferative activity of MBEAS against both melanoma 
and non-melanoma cancer cells. It inhibited the growth of 
A431 and B16F10 cells, showed cytotoxicity by inducing 
apoptosis in both the cell lines. Hence it suggests that A. 
salviifolium has potential to be developed as an anticancer 
agent against skin cancer but for that further detailed study 
including in vivo studies will be required to be carried out to 
better understand the efficacy and implications of A. 
salviifolium in cancer management. 
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